Scarica l'app Stockscreener
4.49
2.60%
-0.12
Dopo l'orario di chiusura:
4.46
-0.03
-0.67%
Taysha Gene Therapies Inc Azioni (TSHA) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
100.00%
-
|
1.986 | 2.302 | 2.022 | 1.788 |
Operating Expenses
|
18.39%
34.02
|
28.74 | 23.72 | 21.95 | 27.69 |
| Benefits Costs and Expenses |
13.39%
32.73
|
28.87 | 23.83 | 20.81 | - |
| Costs And Expenses |
13.39%
32.73
|
28.87 | 23.83 | 20.81 | 27.69 |
| Operating Income/Loss |
27.18%
-34.02
|
-26.75 | -21.42 | -19.93 | -25.90 |
| Nonoperating Income/Loss |
1,101%
1.291
|
-0.129 | -0.108 | 1.147 | 0.374 |
| Income/Loss From Continuing Operations Before Tax |
21.77%
-32.73
|
-26.88 | -21.53 | -18.79 | 1.788 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Income/Loss From Continuing Operations After Tax |
21.77%
-32.73
|
-26.88 | -21.53 | -18.79 | -25.52 |
|
Net Income/Loss
|
21.77%
-32.73
|
-26.88 | -21.53 | -18.79 | -25.52 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
18.56%
353.31
|
297.99 | 269.31 | 6.0824 | 267.82 |
| Diluted Average Shares |
18.56%
353.31
|
297.99 | 269.31 | 6.0824 | 267.82 |
| Basic Earnings Per Share |
0.00%
-0.09
|
-0.09 | -0.08 | -0.07 | -0.10 |
| Diluted Earnings Per Share |
0.00%
-0.09
|
-0.09 | -0.08 | -0.07 | -0.10 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.48%
1.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):